| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200105)44:5<1170::AID-ANR200>3.0.CO;2-T |
| P698 | PubMed publication ID | 11352251 |
| P2093 | author name string | Bennett PH | |
| Knowler WC | |||
| Hanson RL | |||
| Pettitt DJ | |||
| Jacobsson LT | |||
| Turesson C | |||
| Sievers ML | |||
| Pillemer S | |||
| P2860 | cites work | C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study | Q36598316 |
| Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped association. | Q50932001 | ||
| Novel inflammatory markers of coronary risk: theory versus practice. | Q54332281 | ||
| Elevated Levels of Interleukin-6 in Unstable Angina | Q58230354 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Akimel O'odham | Q209148 |
| cardiovascular disease | Q389735 | ||
| P304 | page(s) | 1170-1176 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians | |
| P478 | volume | 44 |
| Q95359383 | Q95359383 |
| Q34981331 | Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases? |
| Q34504806 | Atherosclerosis and connective tissue diseases |
| Q38396964 | Atherosclerosis in rheumatoid arthritis: is it all about inflammation? |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q33806651 | Cardiovascular morbidity and mortality in rheumatoid arthritis |
| Q37956137 | Cardiovascular safety of biologic therapies for the treatment of RA. |
| Q34092449 | Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register. |
| Q77110088 | Early rheumatoid arthritis: a medical emergency? |
| Q55049410 | Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. |
| Q34972556 | Glucocorticoids and rheumatoid arthritis: back to the future? |
| Q46914146 | Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis |
| Q35554431 | Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study |
| Q37245192 | Infliximab improves vascular stiffness in patients with rheumatoid arthritis |
| Q37079259 | Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. |
| Q24812262 | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study |
| Q33224257 | Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. |
| Q56966953 | Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde? |
| Q45129671 | Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis |
| Q37691093 | SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis |
| Q36420808 | Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab |
| Q46458701 | Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q37206876 | The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q40525673 | Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis |
| Q37583248 | Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. |
| Q53837084 | Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients. |
Search more.